Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The ...

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Sun Pharmaceutical Industries, Inc., based in New Jersey, has recalled 9,840 bottles of Morphine Sulfate extended-release ...

StockNews.com upgraded shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a sell rating to a hold rating in a ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

The Delhi High Court recently came to the rescue of a Company engaged in the sale of various pharmaceutical products and ...

Shilpa Medicare has launched its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a ...

Jefferies Financial Group initiated coverage on shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. The firm issued a buy ...

The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.

Darshan Patel’s Fogg rejected the 'woman magnet' gimmick and helped reposition deodorants as a daily essential. 'I wanted a ...